Related Experiment Video
Updated: Jan 6, 2026
Cells and Secretions of the Pancreas
ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor
Hyun-Woo Shin1, Hyunsung Choi2, Daeho So3
1Department of Pharmacology, Seoul National University College of Medicine, Seoul, Korea; Ischemic/Hypoxic Disease Institute, Seoul National University College of Medicine, Seoul, Korea; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.
Immunoglobulin transcription factor 2 (ITF2) suppresses colorectal cancer by inhibiting the beta-catenin pathway. Loss of ITF2 promotes tumor growth and is linked to poorer patient outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Immunoglobulin transcription factor 2 (ITF2) has conflicting roles in cancer, with prior belief in promoting neoplastic transformation.
- Recent findings suggest ITF2 may suppress colon carcinogenesis, necessitating further investigation.
Purpose of the Study:
- To investigate the roles of ITF2 in colorectal cancer cell lines.
- To determine the impact of ITF2 on tumor formation and growth in mice.
- To correlate ITF2 expression with clinical outcomes in patients with colorectal cancer.
Main Methods:
- Quantified ITF2, beta-catenin, and c-Myc levels in human colorectal tumors via immunohistochemistry.
- Analyzed ITF2's regulation of beta-catenin and T-cell factor (TCF) using molecular assays.
- Assessed xenograft tumor growth in mice with altered ITF2 expression levels.
- Correlated ITF2 expression with patient outcomes using colorectal carcinoma tissue arrays.
Main Results:
- ITF2 levels were decreased and c-Myc levels increased in carcinomas compared to adenomas.
- ITF2 negatively regulated the beta-catenin-TCF4 complex and its target genes in colorectal cancer cell lines.
- Overexpression of ITF2 reduced tumor cell proliferation and tumorigenic potential in mice.
- Loss of ITF2 in tumors correlated with poor patient outcomes and shorter survival times.
Conclusions:
- ITF2 inhibits beta-catenin-TCF4 complex activation and target gene transcription in colorectal cancer.
- Loss of ITF2 promotes colorectal cancer cell tumorigenicity and is associated with tumor progression.
- Reduced ITF2 expression is a potential biomarker for adverse clinical outcomes in colorectal cancer patients.
Related Concept Videos
Cells and Secretions of the Pancreas
Exocrine function is carried out by acinar cells, organized into clusters known as acini. These cells contribute to digestion by releasing substantial quantities of enzyme-rich, alkaline digestive juices.
Concurrently, the dispersed clusters of endocrine cells throughout the...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are...
Cell Specific Gene Expression
Insulin Secretory Vesicles
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
The Endocrine System